Back

The impact of interventional or medical therapy on the quality of life assessment in patients suffering from supraventricular tachycardias.

18 March 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Supra ventricular tachycardia Supraventricular Tachycardia (non-AF) - Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Nikolaos Fragakis

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

8 More presentations in this session

Presentation thumbnail
Routine zero-fluoroscopy approach for right-sided EP procedures
Presentation thumbnail
Current management of adult asymptomatic patients with the Wolff-Parkinson-White syndrome: More than the guidelines
Doctor J. Rubio Campal (Madrid, ES)
Abstract Slides
Presentation thumbnail
Radio frequency ablation of the cavotricuspid isthmus in typical atrial flutter coupled with atrial fibrillation
Doctor K. Yergeshov (Almaty, KZ)
Abstract Slides
Presentation thumbnail
Ivabradine as a prevention treatment of inappropriate sinus node tachycardia recurrence
Professor S. Grigoryan (Yerevan, AM)
Presentation thumbnail
3D pace-mapping of Koch's triangle to reduce risk of unexpected atrioventricular block during zero-X-ray ablation of atrioventricular nodal reentrant tachycardia. A pilot study.

Access the full session

Session thumbnail
Poster session 1 - Supra ventricular tachycardia

The Event

Event poster

EHRA 2018

18 March - 20 March 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources